Showing 1 - 8 results of 8 for search 'T. D. Lutskaya', query time: 0.03s Refine Results
  1. 1
    Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma

    Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma by T A Mitina, A K Golenkov, E V Katayeva, T D Lutskaya, E V Trifonona, E F Klinushkina

    Published 2010-07-01
    Get full text
    Article
  2. 2
    INCREASE OF DRUG RESISTANCE OF ACUTE MYELOID LEUKEMIA CELLS IN MULTICELLULAR AGGREGATES IN VITRO

    INCREASE OF DRUG RESISTANCE OF ACUTE MYELOID LEUKEMIA CELLS IN MULTICELLULAR AGGREGATES IN VITRO by S. G. Zakharov, A. K. Golenkov, T. A. Mitina, T. D. Lutskaya, K. A. Belousov, R. S. Fadeev, M. E. Solovieva, A. S. Senotov, V. S. Akatov

    Published 2016-02-01
    Get full text
    Article
  3. 3
    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma

    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma by T. D. Lutskaya, A. K. Golenkov, T. A. Mitina, I. V. Buravtsova, G. A. Dudina, L. L. Vysotskaya, E. V. Trifonova, E. V. Kataeva, O. V. Moskalets, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article
  4. 4
    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma

    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma by T. D. Lutskaya, A. K. Golenkov, T. A. Mitina, I. V. Buravtsova, G. A. Dudina, L. L. Vysotskaya, E. V. Trifonova, E. V. Kataeva, O. V. Moskalets, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article
  5. 5
    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine by E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article
  6. 6
    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice

    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice by A. K. Golenkov, L. L. Vysotskaya, E. V. Trifonova, T. A. Mitina, T. D. Lutskaya, E. V. Kataeva, G. A. Dudina, Yu. B. Chernykh, I. V. Buravtsova, A. N. Gurov, R. V. Gorenkov

    Published 2014-07-01
    Get full text
    Article
  7. 7
    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice

    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice by A. K. Golenkov, L. L. Vysotskaya, E. V. Trifonova, T. A. Mitina, T. D. Lutskaya, E. V. Kataeva, G. A. Dudina, Yu. B. Chernykh, I. V. Buravtsova, A. N. Gurov, R. V. Gorenkov

    Published 2014-07-01
    Get full text
    Article
  8. 8
    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine by E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article

Search Tools: